Paid

Can variability in HbA1c lead to a higher risk of mortality in persons with diabetes?

Does early-onset type 2 diabetes put young patients at a higher risk of developing comorbidities as they become adults?

Evaluating the discordance between laboratory and continuous glucose monitoring estimated HbA1c.

American Diabetes Association mini-symposium presented by Mike Sampson, MD.

The preparation of nasal glucagon is immediate and intended for use in an emergency hypoglycemic event, but how well can it reverse these events? 

Diet and exercise coaches are the future of preventing T2D in patients with overweight or obesity.  

Finerenone is a mineralocorticoid receptor antagonist indicated for chronic kidney disease (CKD) with type 2 diabetes. Does the use of insulin affect its performance against kidney and cardiovascular issues?

Contrary to previous studies, new research finds SGLT-2i more effective for weight loss than GLP-1 RAs as add-on therapy to Metformin. 

With the introduction of this new biosimilar insulin, patients with diabetes will have the opportunity to have easier and broader access to insulin therapy, and a more affordable option than those already on the market. 

Recently completed research examines the effect of consistent cycling on all-cause and cardiovascular mortality.